<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian Journal of Blood and Cancer</title>
<title_fa></title_fa>
<short_title>Iranian Journal of Blood and Cancer</short_title>
<subject>Medical Sciences</subject>
<web_url>http://ijbc.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>2008-4595</journal_id_issn>
<journal_id_issn_online>2008-4609</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.61882/ijbc</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>2008-4595</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1401</year>
	<month>3</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2022</year>
	<month>6</month>
	<day>1</day>
</pubdate>
<volume>14</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Unusual ophthalmic manifestation in chronic myeloid leukemia: A case report</title>
	<subject_fa>Adults Hematology &amp; Oncology</subject_fa>
	<subject>Adults Hematology &amp; Oncology</subject>
	<content_type_fa>گزارش مورد</content_type_fa>
	<content_type>Case report</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;span style=&quot;line-height:2;&quot;&gt;&lt;span style=&quot;font-family:Arial;&quot;&gt;&lt;span style=&quot;font-size:14px;&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Chronic myeloid leukemia (CML) is a myeloproliferative hematopoietic malignancy with a heterogeneous proliferation of hematopoietic cells in the bone marrow. The ocular manifestations are rare symptoms of CML. In this case report, a CML patient with retinal hemorrhage is reported as an uncommon symptom.&lt;br&gt;
&lt;strong&gt;Case presentation: &lt;/strong&gt;A 35-year-old man was referred due to decreased right eye&amp;nbsp;vision. The reduction of the visual acuity of the right eye (2/10), rounded and diffuse intra-retinal hemorrhage with white-center Roth&amp;rsquo;s spots, and macular edema were seen. No systemic diseases and other ophthalmic manifestations were seen in this case. The white blood cell (WBC) count was 135,000 cells/ &amp;mu;l, the platelets were 430,000 cells/&amp;mu;l, and hemoglobin was 12.5 gr/dl. The myeloid progenitor and precursor were present in peripheral blood smear and bone marrow. Also, the quantitative real-time polymerase chain reaction indicated that the BCR-ABL1-to-ABL1 ratio was 0.795. a daily administration of 400 mg of Imatinib was prescribed. Two months later, WBC count reached 6,500 cells/&amp;mu;l, Hb was 11.6 gr/dl, and platelets were 306,000 cells/&amp;mu;l.&lt;br&gt;
&lt;strong&gt;Conclusion:&lt;/strong&gt;&amp;nbsp;The ophthalmic manifestations may be a symptom of CML. We found the rounded and diffuse intra-retinal hemorrhage, Roth&amp;rsquo;s spots, and macular edema as the ocular manifestation of a CML case.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Chronic myeloid leukemia, Visual acuity, Roth's spots, Ophthalmic manifestations</keyword>
	<start_page>58</start_page>
	<end_page>60</end_page>
	<web_url>http://ijbc.ir/browse.php?a_code=A-10-731-1&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Mohsen</first_name>
	<middle_name></middle_name>
	<last_name>Vakili</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>mohsen.v@gmail.com</email>
	<code>10031947532846008956</code>
	<orcid>10031947532846008956</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>School of Medicine, Babol University of Medical Sciences, Babol, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Seyed Ahmad</first_name>
	<middle_name></middle_name>
	<last_name>Rasoulinejad</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>Seyedahmadrasoulinejad@gmail.com</email>
	<code>10031947532846008957</code>
	<orcid>10031947532846008957</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>Department of Ophthalmology, Ayatollah Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
